GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
289 hedge funds and large institutions have $2.23B invested in GW Pharmaceuticals Plc American Depositary Shares in 2020 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 77 increasing their positions, 94 reducing their positions, and 59 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
9% less funds holding
Funds holding: 318 → 289 (-29)
14% less capital invested
Capital invested by funds: $2.59B → $2.23B (-$356M)
18% less repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 94
41% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 59
47% less call options, than puts
Call options by funds: $55.7M | Put options by funds: $105M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$86.1M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$74.1M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$45.4M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$36M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$34.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$63.2M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$57.1M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$47.5M |
| 4 |
Renaissance Technologies
New York
|
-$26.2M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$23.9M |
GWPH Hedge Fund Activity: Q1 2020 in Review
289 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q1 2020, worth a combined $2.23B — down 14% from $2.59B a quarter earlier.
Sellers outnumbered buyers: 59 funds closed out of GWPH and 35 opened new positions — a net loss of 24 holders — while 94 trimmed existing stakes and 77 added.
The largest buyer was Janus Henderson Group, adding an estimated $86.1M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $63.2M sold.
- 289 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q1 2020, down from 318 in Q4 2019.
- Funds reported $2.23B of GW Pharmaceuticals Plc American Depositary Shares stock for Q1 2020, down 14% quarter-over-quarter.
- 35 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q1 2020 and 59 closed out, a net change of -24 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q1 2020 was Janus Henderson Group, an estimated $86.1M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q1 2020 was Consonance Capital Management, an estimated $63.2M sold.
Based on aggregated 13F filings for Q1 2020.